Target intelligence / Profile preview

RNA, U4 small nuclear 52, pseudogene (RNU4-52P)

Target
RNU4-52P
Molecular classification
Other (Pseudogene)
01

Overview

RNU4-52P is the designation for a pseudogene related to U4 small nuclear RNA, specifically the 52nd locus annotated in the human genome. Pseudogenes are genetic sequences that resemble functional genes but are generally non-coding and not transcribed or translated into functional RNA or protein. Unlike functional U4 snRNA genes (such as RNU4-2), which are core components of the spliceosome and play essential roles in pre-mRNA splicing and have clinical implications in neurodevelopmental disease, RNU4-52P itself is a pseudogene without documented biological function, therapeutic relevance, or disease association. There are no known drugs, molecular interactions, or biomarker utilities related to RNU4-52P. Clarification on Confusion: There is significant recent interest in functional U4 snRNA genes (such as RNU4-2), as mutations in these can cause neurodevelopmental syndromes. However, RNU4-52P is a pseudogene and not part of these disease mechanisms. If your interest is in the functional U4 small nuclear RNA involved in disease (for example, RNU4-2), refer to that specific gene, not the pseudogene. Summary: RNU4-52P is not a functional gene, not a drug target, and does not have known biomedical relevance. If you intended information on a functional U4 snRNA gene, please specify RNU4-2 or a similar gene.

Other names
RNU4-52P

Beyond the preview

Go deeper on RNA, U4 small nuclear 52, pseudogene (RNU4-52P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U4 small nuclear 52, pseudogene (RNU4-52P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call